{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:37:20Z","timestamp":1764700640449,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T00:00:00Z","timestamp":1512518400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001184","name":"Cure Cancer Australia Foundation","doi-asserted-by":"publisher","award":["APP632547"],"award-info":[{"award-number":["APP632547"]}],"id":[{"id":"10.13039\/501100001184","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["APP632547"],"award-info":[{"award-number":["APP632547"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["Novel Concept Award"],"award-info":[{"award-number":["Novel Concept Award"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10585-017-9868-4","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T13:38:27Z","timestamp":1512567507000},"page":"3-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2911-885X","authenticated-orcid":false,"given":"Patsy S.","family":"Soon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela J.","family":"Provan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmala","family":"Pathmanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinny","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary L.","family":"Balleine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,6]]},"reference":[{"key":"9868_CR1","doi-asserted-by":"crossref","DOI":"10.1201\/9780203852569","volume-title":"The biology of cancer","author":"RA Weinberg","year":"2006","unstructured":"Weinberg RA (2006) The biology of cancer. Garland Science, New York"},{"issue":"1","key":"9868_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1677\/erc.0.0080047","volume":"8","author":"DC Allred","year":"2001","unstructured":"Allred DC, Mohsin SK, Fuqua SA (2001) Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8(1):47\u201361","journal-title":"Endocr Relat Cancer"},{"issue":"14","key":"9868_CR3","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","volume":"350","author":"HJ Burstein","year":"2004","unstructured":"Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM (2004) Ductal carcinoma in situ of the breast. N Engl J Med 350(14):1430\u20131441","journal-title":"N Engl J Med"},{"issue":"2","key":"9868_CR4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1078-0432.CCR-07-1127","volume":"14","author":"DC Allred","year":"2008","unstructured":"Allred DC, Wu Y, Mao S, Nagtegaal ID, Lee S, Perou CM, Mohsin SK, O\u2019Connell P, Tsimelzon A, Medina D (2008) Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14(2):370\u2013378","journal-title":"Clin Cancer Res"},{"issue":"5","key":"9868_CR5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10(5):593\u2013601","journal-title":"Nat Cell Biol"},{"key":"9868_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1471-2407-14-51","volume":"14","author":"KA Avery-Kiejda","year":"2014","unstructured":"Avery-Kiejda KA, Braye SG, Mathe A, Forbes JF, Scott RJ (2014) Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer. BMC Cancer 14:51. https:\/\/doi.org\/10.1186\/1471-2407-14-51","journal-title":"BMC Cancer"},{"issue":"21","key":"9868_CR7","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1093\/nar\/gkn725","volume":"36","author":"P Mestdagh","year":"2008","unstructured":"Mestdagh P, Feys T, Bernard N, Guenther S, Chen C, Speleman F, Vandesompele J (2008) High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res 36(21):e143. https:\/\/doi.org\/10.1093\/nar\/gkn725","journal-title":"Nucleic Acids Res"},{"key":"9868_CR8","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"MW Pfaffl","year":"2002","unstructured":"Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"9868_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10911-009-9160-6","volume":"14","author":"JD Graham","year":"2009","unstructured":"Graham JD, Mote PA, Salagame U, Balleine RL, Huschtscha LI, Clarke CL (2009) Hormone-responsive model of primary human breast epithelium. J Mammary Gland Biol Neoplasia 14(4):367\u2013379. https:\/\/doi.org\/10.1007\/s10911-009-9160-6","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"7","key":"9868_CR10","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1210\/en.2008-1630","volume":"150","author":"JD Graham","year":"2009","unstructured":"Graham JD, Mote PA, Salagame U, van Dijk JH, Balleine RL, Huschtscha LI, Reddel RR, Clarke CL (2009) DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology 150(7):3318\u20133326. https:\/\/doi.org\/10.1210\/en.2008-1630","journal-title":"Endocrinology"},{"issue":"11","key":"9868_CR11","doi-asserted-by":"publisher","first-page":"e8003","DOI":"10.1371\/journal.pone.0008003","volume":"4","author":"R Navon","year":"2009","unstructured":"Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, Yakhini Z (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS ONE 4(11):e8003. https:\/\/doi.org\/10.1371\/journal.pone.0008003","journal-title":"PLoS ONE"},{"issue":"10","key":"9868_CR12","doi-asserted-by":"publisher","first-page":"13414","DOI":"10.3390\/ijms131013414","volume":"13","author":"J Tang","year":"2012","unstructured":"Tang J, Ahmad A, Sarkar FH (2012) The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci 13(10):13414\u201313437. https:\/\/doi.org\/10.3390\/ijms131013414","journal-title":"Int J Mol Sci"},{"issue":"8","key":"9868_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/1055-9965.epi-12-0173","volume":"21","author":"S Mattiske","year":"2012","unstructured":"Mattiske S, Suetani RJ, Neilsen PM, Callen DF (2012) The oncogenic role of miR-155 in breast cancer. Cancer Epidemiol Biomarkers Prev 21(8):1236\u20131243. https:\/\/doi.org\/10.1158\/1055-9965.epi-12-0173","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"9868_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/jso.22153","volume":"106","author":"J Chen","year":"2012","unstructured":"Chen J, Wang BC, Tang JH (2012) Clinical significance of microRNA-155 expression in human breast cancer. J Surg Oncol 106(3):260\u2013266. https:\/\/doi.org\/10.1002\/jso.22153","journal-title":"J Surg Oncol"},{"issue":"3","key":"9868_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ygyno.2010.07.021","volume":"119","author":"F Wang","year":"2010","unstructured":"Wang F, Zheng Z, Guo J, Ding X (2010) Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 119(3):586\u2013593. https:\/\/doi.org\/10.1016\/j.ygyno.2010.07.021","journal-title":"Gynecol Oncol"},{"issue":"5","key":"9868_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/jcp.2008.060681","volume":"62","author":"SM Khoshnaw","year":"2009","unstructured":"Khoshnaw SM, Green AR, Powe DG, Ellis IO (2009) MicroRNA involvement in the pathogenesis and management of breast cancer. J Clin Pathol 62(5):422\u2013428. https:\/\/doi.org\/10.1136\/jcp.2008.060681","journal-title":"J Clin Pathol"},{"issue":"16","key":"9868_CR17","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.can-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065\u20137070. https:\/\/doi.org\/10.1158\/0008-5472.can-05-1783","journal-title":"Cancer Res"},{"issue":"12","key":"9868_CR18","doi-asserted-by":"publisher","first-page":"e80707","DOI":"10.1371\/journal.pone.0080707","volume":"8","author":"S Huang","year":"2013","unstructured":"Huang S, Chen Y, Wu W, Ouyang N, Chen J, Li H, Liu X, Su F, Lin L, Yao Y (2013) miR-150 promotes human breast cancer growth and malignant behavior by targeting the pro-apoptotic purinergic P2 \u00d7 7 receptor. PLoS ONE 8(12):e80707. https:\/\/doi.org\/10.1371\/journal.pone.0080707","journal-title":"PLoS ONE"},{"issue":"3","key":"9868_CR19","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.trsl.2013.11.005","volume":"163","author":"K Jang","year":"2014","unstructured":"Jang K, Ahn H, Sim J, Han H, Abdul R, Paik SS, Chung MS, Jang SJ (2014) Loss of microRNA-200a expression correlates with tumor progression in breast cancer. Transl Res 163(3):242\u2013251. https:\/\/doi.org\/10.1016\/j.trsl.2013.11.005","journal-title":"Transl Res"},{"issue":"5","key":"9868_CR20","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3892\/ijmm.2015.2123","volume":"35","author":"F Wang","year":"2015","unstructured":"Wang F, Lv P, Liu X, Zhu M, Qiu X (2015) microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53. Int J Mol Med 35(5):1395\u20131402. https:\/\/doi.org\/10.3892\/ijmm.2015.2123","journal-title":"Int J Mol Med"},{"issue":"11","key":"9868_CR21","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.bbadis.2016.08.014","volume":"1862","author":"YF Pei","year":"2016","unstructured":"Pei YF, Lei Y, Liu XQ (2016) MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1. Biochim Biophys Acta 1862(11):2177\u20132185. https:\/\/doi.org\/10.1016\/j.bbadis.2016.08.014","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"9868_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4048\/jbc.2014.17.2.143","volume":"17","author":"U Berber","year":"2014","unstructured":"Berber U, Yilmaz I, Narli G, Haholu A, Kucukodaci Z, Demirel D (2014) miR-205 and miR-200c: predictive micro RNAs for lymph node metastasis in triple negative breast cancer. J Breast Cancer 17(2):143\u2013148. https:\/\/doi.org\/10.4048\/jbc.2014.17.2.143","journal-title":"J Breast Cancer"},{"key":"9868_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-015-0337-x","volume":"14","author":"SA Rasheed","year":"2015","unstructured":"Rasheed SA, Teo CR, Beillard EJ, Voorhoeve PM, Zhou W, Ghosh S, Casey PJ (2015) MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Mol Cancer 14:67. https:\/\/doi.org\/10.1186\/s12943-015-0337-x","journal-title":"Mol Cancer"},{"issue":"3","key":"9868_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12094-015-1364-1","volume":"18","author":"F Xu","year":"2016","unstructured":"Xu F, He H, Huang W, Lin Y, Luo S, Du Q, Duan R (2016) Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis. Clin Transl Oncol 18(3):283\u2013288. https:\/\/doi.org\/10.1007\/s12094-015-1364-1","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"9868_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bbrc.2013.10.025","volume":"441","author":"Z Wang","year":"2013","unstructured":"Wang Z, Liao H, Deng Z, Yang P, Du N, Zhanng Y, Ren H (2013) miRNA-205 affects infiltration and metastasis of breast cancer. Biochem Biophys Res Commun 441(1):139\u2013143. https:\/\/doi.org\/10.1016\/j.bbrc.2013.10.025","journal-title":"Biochem Biophys Res Commun"},{"key":"9868_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13058-015-0526-y","volume":"17","author":"E Schooneveld van","year":"2015","unstructured":"van Schooneveld E, Wildiers H, Vergote I, Vermeulen PB, Dirix LY, Van Laere SJ (2015) Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Res 17:21. https:\/\/doi.org\/10.1186\/s13058-015-0526-y","journal-title":"Breast Cancer Res"},{"issue":"15","key":"9868_CR27","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/cncr.26711","volume":"118","author":"EA Rakha","year":"2012","unstructured":"Rakha EA, Martin S, Lee AH, Morgan D, Pharoah PD, Hodi Z, Macmillan D, Ellis IO (2012) The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer 118(15):3670\u20133680. https:\/\/doi.org\/10.1002\/cncr.26711","journal-title":"Cancer"},{"issue":"5","key":"9868_CR28","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/s1470-2045(07)70140-7","volume":"8","author":"M Bockhorn","year":"2007","unstructured":"Bockhorn M, Jain RK, Munn LL (2007) Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8(5):444\u2013448. https:\/\/doi.org\/10.1016\/s1470-2045(07)70140-7","journal-title":"Lancet Oncol"},{"issue":"10","key":"9868_CR29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/nm.2459","volume":"17","author":"S Chang","year":"2011","unstructured":"Chang S, Wang RH, Akagi K, Kim KA, Martin BK, Cavallone L, Haines DC, Basik M, Mai P, Poggi E, Isaacs C, Looi LM, Mun KS, Greene MH, Byers SW, Teo SH, Deng CX, Sharan SK (2011) Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 17(10):1275\u20131282. https:\/\/doi.org\/10.1038\/nm.2459","journal-title":"Nat Med"},{"issue":"22","key":"9868_CR30","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1128\/mcb.00941-08","volume":"28","author":"W Kong","year":"2008","unstructured":"Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ (2008) MicroRNA-155 is regulated by the transforming growth factor beta\/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28(22):6773\u20136784. https:\/\/doi.org\/10.1128\/mcb.00941-08","journal-title":"Mol Cell Biol"},{"issue":"7","key":"9868_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nm.3886","volume":"21","author":"LR Yates","year":"2015","unstructured":"Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, Aas T, Alexandrov LB, Larsimont D, Davies H, Li Y, Ju YS, Ramakrishna M, Haugland HK, Lilleng PK, Nik-Zainal S, McLaren S, Butler A, Martin S, Glodzik D, Menzies A, Raine K, Hinton J, Jones D, Mudie LJ, Jiang B, Vincent D, Greene-Colozzi A, Adnet PY, Fatima A, Maetens M, Ignatiadis M, Stratton MR, Sotiriou C, Richardson AL, Lonning PE, Wedge DC, Campbell PJ (2015) Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med 21(7):751\u2013759. https:\/\/doi.org\/10.1038\/nm.3886","journal-title":"Nat Med"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-017-9868-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-017-9868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-017-9868-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T22:26:52Z","timestamp":1603492012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-017-9868-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,6]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["9868"],"URL":"https:\/\/doi.org\/10.1007\/s10585-017-9868-4","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"type":"print","value":"0262-0898"},{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2017,12,6]]}}}